E300G (p.Glu300Gly) variant of GCK (Hexokinase-4)

E300G (p.Glu300Gly) in GCK (Hexokinase-4) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Maturity-onset diabetes of the young; Monogenic diabetes. The record also includes published literature and structural context.

E300G (p.Glu300Gly) variant details